Welcome to the Diabetes and Cardiovascular Disease EASD Study Group (D&CVD) information page.
The D&CVD became an official EASD study group as of September
2007.
Below you will find some information regarding the D&CVD objectives, Executive
Committee, membership and educational initiatives. If you would like more
information, please contact President Antonio Ceriello via email at
ACERIELL@clinic.ub.es.
The Diabetes and Cardiovascular Disease EASD Study Group (D&CVD) is a newly
formed study group that exists to:
Promote advancement of knowledge on all aspects of cardiovascular disease and
diabetes through active co-operation between interested diabetologists and other
specialists, particularly cardiologists
Bring together researchers working in the field of cardiovascular disease in
diabetes to
exchange experiences in research and to promote discussions during
regular meetings
Work actively for the establishment of European and international collaborative
studies
Act as a reference group for the EASD in matters related to cardiovascular
disease and
diabetes
The initial
meeting of the D&CVD was held on January 19-21,
There were 70
attendees, including many members of the EASD
The following
Executive Committee was
elected:
|
Title |
Name |
Term |
|
President |
Prof
Antonio Ceriello, |
3 years |
|
Vice-President |
Prof
|
2 years |
|
Secretary |
Dr Carlo B Giorda, Italy |
4 years |
|
Additional Members |
Prof Nicolae Hancu, Romania |
3 years |
|
Dr John Petrie, UK |
3 years |
|
|
Prof Oliver Schnell, Germany |
2 years |
|
|
Prof Paul Valensi, France |
2 years |
New membership during this inaugural year is open to all members of the EASD who
attend the D&CVD annual meeting
New membership in subsequent years will be open to all members of the EASD who
present an abstract during the annual meeting
To view the D&CVD regulations click
here
_______________________________________________________________________________________________________
2010
Initiatives
The D&CVD shall meet on an annual basis for a scientific and business meeting
to:
Provide a forum for collaboration regarding research and advancements
Discuss future goals and upcoming initiatives
Determine new Executive Committee members
_______________________________________________________________________________________________________
Sanofi-Aventis
SILVER Sponsors:
Bayer
Schering Pharma & Bayer Diabetes Care
Pfizer
Novo Nordisk
PRESIDENT:
Prof Antonio Ceriello,
MD PhD
Institut
d'Investigacions
Biomèdiques
August Pi i Sunyer- IDIBAPS
Mallorca, 183
08036 Barcelona
Phone: +34 93 227 54 00 ext.4390
E-mail:
ACERIELL@clinic.ub.es
SECRETARIAT
Ref. Elisa Cristofori
Tel. +39 010 505385
Tel. +39 010 5298168
Fax. +39 010 8992719
E-mail:
e.cristofori@ecmservice.it
Site l